Umbilical cord blood as a source of stem cells;Umbilikalna krv kao izvor matičnih stanica

Acta Medica Croatica

Volumn 60, Issue 3, 2006, Pages 215-225

  Bojanić, Ines ^a   Ćepulić, Branka Golubić ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Stem cell transplantation; Umbilical cord blood

Indexed keywords

LIQUID NITROGEN;

APLASIA; ARTICLE; BLOOD BANK; BLOOD DISEASE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL PRACTICE; CRYOPRESERVATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEALTH PROGRAM; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LYMPHOCYTE COUNT; MORBIDITY; MORTALITY; MULTIPOTENT STEM CELL; MYCOSIS; NONHUMAN; PLASTICITY; RECURRENT DISEASE; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VASCULARIZATION; VIRUS INFECTION; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; REVIEW;

BLOOD BANKS; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 33750582374     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Knudtzon S. In vitro growth of granulocyte colonies from circulating cells in human blood. Blood 1974; 43: 357-61.
2. Gluckman E, Broxmeyer HE, Auerbach AD i sur. Haematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 32: 1174-91.
3. Cord blood banking for potential future transplantation: subject review. American Academy of Pediatries. Work Group on Cord Blood Banking. Pediatrics 1999; 104: 116-8.
4. Dugan M, Han CS, McGlave PB. Committed and primitive progenitor content of umbilical cord blood CD34+ subpopulations. Exp Hematol 1994; 22: 791.
5. Traycoff CM, Abboud MR, Laver J i sur. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994; 22: 215-22.
6. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34+ CD38- cells in cord blood and bone marrow. Blood 1995; 86: 3745-53.
7. Broxmeyer HE, Kurtzberg J, Gluckman E i sur. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991; 17: 313-29.
8. Han CS, Dugan MJ, Verfaillie CM i sur. In vitro expansion of umbilical cord blood committed and primitive progenitors. Exp Hematol 1994; 22: 723.
9. Traycoff CM, Abboud MR, Laver J i sur. Rapid exit from G00 /G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells and enhanced ex vivo expansion potential. Exp Hematol 1994; 22: 1264-72.
10. Vaziri H, Dragowska W, Aallsopp RC i sur. Evidence for mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994; 91: 9857-60.
11. Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwnhuis HK. Alloceneic bone marrow transplantation with a fixed low number of T cells in the marow graft. Blood 1994; 83: 3090-6.
12. Rainaut M, Pagniez M, Hercend i sur. Characterization of mononuclear cell subpopulations in normal fetal peripheral blood. Hum Immunol 1987; 18: 331-7.
13. Clement LT, Vink PE, Bradley GE. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J Immunol 1990; 145: 102-8.
14. Roncarolo MG, Bigler M, Ciuti E i sur. Immune responses by cord blood cells. Blood Cells 1994; 20: 573-86.
15. Roncarolo MG, Vaccarino E, Caracco P. Immunologic properties of umbilical cord blood. U: Brocmeyer HA, ur. Cellular Characteristics of Cord Blood and Cord Blood Transplantation. Bethesda: AABB Press, 1998, 67-72.
16. Solves P, Mirabet V, Larrea L i sur. Comparison between two cord blood collection strategies. Acta Obstet Gynecol Scand 2003; 82: 439-42.
17. Pafumi C, Farina M, Bandiera S i sur. Differences in umbilical cord blood units collected during cesarean section, before or after the delivery of the placenta. Gynecol Obstet Invest 2002; 54(2): 73-7.
18. Rubinstein P, Carrier C, Taylor P i sur. Placental and umbilical cord blood banking for unrelated marrow reconstitution. U: Brecher ME, Lasky LC, Sacher RA, Issit LA, ur. Hematopoietic progenitor cells: Processing, standards and practice. Bethesda: AABB Press, 1995, 1-17.
19. Broxmeyer HE, Hangoc G, Cooper C. Clinical and biological aspects of human umbilical cord blood as a source of transplantable hematopoietic stem cells. Bone Marrow Transplant 1992; 9: 7-10.
20. Lasky LC, McCullough J, Zanjaji ED. Liquid storage of unseparated human bone marrow: Evaluation of hematopoietic progenitors by clonal assay. Transfusion 1986; 26: 331-334.
21. Rebulla P, Lecchi L, Porretti L i sur. Practical placental blood banking. Trans Med Rev 1999; 13: 205-26.
22. Council of Europe. Guide to safety and quality assurance for organs, tissues and cells. 2nd edition. Council of Europe Publishing. Strasbourg 2004.: 21-38.
23. Webb IJ. Umbilical cord blood as a source of progenitor cells to reconstitute hematopoiesis. Trans Med Rev 1997; 11: 265-73.
24. Gluckman E, Rocha V, Boyer-Chammard A i sur. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-81.
25. Rubinstein P, Dobrila L, Rosenfield RE i sur. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995; 92: 10119-22.
26. Benito AI, Diaz MA, Gonzalez-Vincet M, Sevilla J, Madero L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675-90.
27. Gluckman E, Rocha V, Chastang C. Cord blood banking and transplant in Europe. Vox Sang 1998; 74 (Suppl 2): 95-101.
28. Cohen Y, Nagler A. Cord blood biology and transplantation. Isr Med Assoc J 2004; 6: 39-46.
29. Kaufman RL, Gunter KC, Visser JWM. Related and autologous cord blood banking and transplantation. U: Broxmeyer HE, ur. Cord Blood: Biology, Immunology, Banking, and Clinical transplantation. Bethesda, MD: AABB Press, 2004: 259-300.
30. Kletzel M, Frader J. Ethical issues in stem cell tranplantation. J Hematotherapy 1998; 7: 197-203.
31. Wall DA, Noffsinger JM, Mueckl KA i sur. Feasibility of an obstetrician-based cord blood collection network for unrelated donor umbilical cord blood banking. J Matern Fetal Med 1997; 6: 320-3.
32. Bender JG, Unverzagt K, Walker DE i sur. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol 1994; 70: 10-8.
33. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28: 1197-205.
34. Rubinstein P, Carrier C, Scaradyvou A i sur. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.
35. Laughlin MJ. Umbilical cord blood for allogenic transplantation in children and adults. Bone Marrow Transplant 2001; 27: 1-6.
36. Laughlin MJ, Barker J, Bambach B i sur. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-22.
37. Moretta A, Maccario R, Fagioli F i sur. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371-9.
38. Gluckman E. Hematopoietic stem cell transplants using umbilical cord blood. N Engl J Med 2001; 344: 1860-1.
39. Wadlow RC, Porter DL. Umbilical cord blood transplantation: where do we stand? Biol Blood Marrow Transplant 2002; 8: 637-17.
40. McGlave PB, Shu XO, Wen W i sur. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program. Blood 2000; 95: 2219-25.
41. Rocha V, Wagner JE Jr, Sobocinski KA i sur. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846-54.
42. Rocha V, Cornish J, Sievers EL i sur. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-71.
43. Gluckman E. Hematopoietic stem-cell transplants using umbilical cord blood. N Engl J Med 2001; 344: 1860-1.
44. Bogdanić V, Nemet D, Kaštelan A i sur. Umbilical cord blood transplantation in patient with Philadelphia chromosome positive chronic myeloid leukemia. Transplantation 1993; 56: 477-9.
45. Mackin W, Gunter KC, Kraus M. The frontier of cellular medicine: expanding umbilical cord blood stem cells for clinical use. Cancer J 2001; 7(Supl 2.): S95-105.
46. Kogler G, Nürnberger W, Fischer J i sur. Simultaneous cord blood transplantation for ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 1999; 24: 397-403.
47. Barker J, Weisdorf D, DeFor T, Davies S, Verfaillie C, Wagner J. Impact of multiple unit unrelated donor umbilical cord blood transplantation in adults: preliminary analysis of safety and efficacy. Blood 2001; 98: 666a. Abstract 2791.
48. Gryn J, Harris D, Shadduck R i sur. Multiple unmatched umbilical cord units for adult allogeneic transplantation. Blood 2001; 98: 666a. Abstract 2792.
49. Querol S, Capmany G, Cancelas JA, Garcia J. Expansion of cord blood progenitor cells. Bone Marrow Transplant 1998; 21(Suppl 3): S77-S80.
50. Pecora AL, Stiff P, Jennis A i sur. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000; 25: 797-9.
51. Shpall EJ, Quinones R, Giller R i sur. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368-76.
52. Kohn DB, Weinberg KL, Nolta JA i sur. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995; 10: 1-7.
53. Shi Q, Rafii S, Wu MH i sur. Evidence for circulating bone marrow derived endothelial cells. Blood 1998; 92: 362-7.
54. Orlic D, Kajstura J, Chimenti S i sur. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
55. Theise ND, Nimmakayalu M, Gardner R i sur. Liver from bone marrow in humans. Hepatology 2000; 32: 11-6.
56. Ferrari G, Cusella-De Angelis G, Coletta M i sur. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-30.
57. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290: 1779-82.
58. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615-25.
59. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA. Multilienage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001; 7: 581-8.
60. Chen J, Sandberg PR, LI Y i sur. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32: 2682-8.
61. Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 2000; 67: 53-9.